All Article Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
LATEST RECOMMENDATION
Eric Daar, University of California, Los Angeles, USA. F1000 Infectious Diseases
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
9 Recommendations, most recent by
Guy Zimmerman, University of Utah, USA. F1000 Cell Biology
- Confirmation
- Controversial
- Good for Teaching
- Interesting Hypothesis
- New Finding
Past 7 Days
361
New Recommendations
138,748 total
285
New Articles Recommended
106,918 total
Past 30 Days
-
246Articles Classified As Good for Teaching2,693 total
-
68Articles Classified As Review / Commentary4,022 total
-
120Articles Classified As Controversial9,530 total
-
172Articles Classified As Technical Advance21,771 total
-
254Articles Classified As Confirmation25,136 total
-
98Articles Classified As Novel Drug Target5,661 total
-
12Articles Classified As Refutation1,493 total
-
187Articles Classified As Clinical Trial12,579 total
-
4Articles Classified As Changes Clinical Practice1,448 total
-
274Articles Classified As Interesting Hypothesis25,913 total
-
852Articles Classified As New Finding99,532 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
